DURBECEM
DEAD

Serial Number

88921864

Owner

Celgene Corporation

Attorney

Marilyn F. Kelly

Filing Date

May 18, 2020

Add to watchlist:

No watchlists yet
View on USPTO

DURBECEM Trademark

Serial Number: 88921864

DURBECEM is a trademark filed by Celgene Corporation on May 18, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

May 18, 2020

Registration Date

Not Registered

Published for Opposition

March 2, 2021

Goods & Services

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 9, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 9, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 20, 2024 EXRA
SOU EXTENSION 5 GRANTED
Aug 20, 2024 EX5G
SOU EXTENSION 5 FILED
Aug 20, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 20, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 9, 2024 EXRA
SOU EXTENSION 4 GRANTED
Feb 7, 2024 EX4G
SOU EXTENSION 4 FILED
Feb 7, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 7, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 31, 2023 EXRA
SOU EXTENSION 3 GRANTED
Aug 29, 2023 EX3G
SOU EXTENSION 3 FILED
Aug 29, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 29, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 1, 2023 EXRA
SOU EXTENSION 2 GRANTED
Feb 27, 2023 EX2G
SOU EXTENSION 2 FILED
Feb 27, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 27, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 25, 2022 EXRA
SOU EXTENSION 1 GRANTED
Aug 23, 2022 EX1G
SOU EXTENSION 1 FILED
Aug 23, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 23, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 4, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 4, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 4, 2022 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 1, 2022 NOAM
TTAB RELEASE CASE TO TRADEMARKS
Jan 6, 2022 TMBN
OPPOSITION TERMINATED NO. 999999
Jan 6, 2022 OP.T
OPPOSITION DISMISSED NO. 999999
Jan 6, 2022 OP.D
OPPOSITION INSTITUTED NO. 999999
Jun 25, 2021 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 28, 2021 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 2, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 27, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 11, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 18, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 18, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 18, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 15, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 4, 2020 NWOS
NEW APPLICATION ENTERED
May 21, 2020 NWAP